Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06750458 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completed without a posted recruiting period Primary completion date changed from estimate of Oct 20, 2026 to Sep 20, 2026 · Study sites: 0 to 1 · Start date changed from estimate of Aug 20, 2025 to Jan 20, 2025 · 3 more Show 6 more changesShow less
    • Primary completion date changed from estimate of Oct 20, 2026 to Sep 20, 2026
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 20, 2025 to Jan 20, 2025
    • Eligibility criteria expanded, about 15 words
    • Publications: details revised at 4 of 4 entries
    • Study description expanded, about 4 words
  2. Primary completion date: Jan 20, 2026 to Oct 20, 2026 Start date: Jan 20, 2025 to Aug 20, 2025 · Completion date: Mar 20, 2026 to Dec 20, 2026v2 Show 2 more changesShow less
    • Start date: Jan 20, 2025 to Aug 20, 2025
    • Completion date: Mar 20, 2026 to Dec 20, 2026
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tanta University
394 trials monitored
See 11 trials at risk
Glioma
668 trials monitored
See 40 trials at risk
The aim of the study is to compare between the role of dapagliflozin versus dexamethasone in pre-operative management of non-diabetic glioma patients on levetiracetam as anti-seizure drug.
Trial Details
NCT Number NCT06750458
Lead Sponsor Tanta University
Conditions Glioma, Dapagliflozin (Forxiga), Dexamethasone
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov